Beyond Bribery and Corruption: Enforcement Trends in Global Healthcare Compliance
This article was originally published in SRA
Lincoln Tsang, Silvia Valverde and Jacqueline Mulryne explore how healthcare product companies are increasingly coming under the scrutiny of regulators worldwide.
You may also be interested in...
India’s Cadila Healthcare, which has been suffering on the earnings front, is amalgamating four subsidiaries under its roof to reduce overheads from managing separate entities and avoid duplication of efforts after posting weak second-quarter earnings.
GemVax unveils positive topline results for South Korean Phase II study of novel peptide drug targeting patients with moderate to severe Alzheimer’s disease, raising hopes for the upcoming US trials.